Compare SUJA & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SUJA | PALI |
|---|---|---|
| Founded | N/A | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 426.8M | 359.0M |
| IPO Year | 2026 | 2019 |
| Metric | SUJA | PALI |
|---|---|---|
| Price | $9.12 | $2.02 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $11.29 |
| AVG Volume (30 Days) | 710.1K | ★ 1.7M |
| Earning Date | N/A | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 97.06 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $260,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 1500.39 |
| 52 Week Low | $5.59 | $0.55 |
| 52 Week High | $11.93 | $2.86 |
| Indicator | SUJA | PALI |
|---|---|---|
| Relative Strength Index (RSI) | 49.06 | 50.15 |
| Support Level | $8.80 | $1.81 |
| Resistance Level | $10.94 | $2.18 |
| Average True Range (ATR) | 0.70 | 0.10 |
| MACD | -0.04 | -0.00 |
| Stochastic Oscillator | 9.60 | 42.19 |
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.